EyeCyte News
Most Popular EyeCyte Story
Pfizer expands adult stem cell therapy work
Pfizer is steadily expanding its presence in the stem cell field. The Wall Street Journal notes that in November the pharma giant will open a regenerative medicine shop in Cambridge, England. It... Read more...
Latest Headlines
- September 30, 2008
- June 24, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
